CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4/GSK3β/β-cateninT120/TCF21 pathway

CXCL12 promotes atherosclerosis by downregulating ABCA1 expression via the CXCR4/GSK3β/β-cateninT120/TCF21 pathway

CXC chemokine ligand 12 (CXCL12) is a member of the CXC chemokine family and mainly acts on cell chemotaxis. CXCL12 also elicits a proatherogenic role, but the molecular mechanisms have not been fully defined yet. We aimed to reveal if and how CXCL12 promoted atherosclerosis via regulating lipid met...

Full description

Bibliographic Details
Main Authors:	Jia-Hui Gao, Lin-Hao He, Xiao-Hua Yu, Zhen-Wang Zhao, Gang Wang, Jin Zou, Feng-Jiao Wen, Li Zhou, Xiang-Jun Wan, Da-Wei Zhang, Chao-Ke Tang
Format:	Article
Language:	English
Published:	Elsevier 2019-12-01
Series:	Journal of Lipid Research
Subjects:	CXC chemokine ligand 12 CXC chemokine receptor 4 ATP binding cassette transporter A1 cholesterol efflux glycogen synthase kinase 3β transcription factor 21
Online Access:	http://www.sciencedirect.com/science/article/pii/S0022227520310415

Similar Items

Effective Treatments for Bladder Cancer Affecting CXCL9/CXCL10/CXCL11/ CXCR3 Axis: A Review
by: Alireza Nazari, et al.
Published: (2020-03-01)

ELR positive CXCL chemokines are highly expressed in an animal model of ulcerative colitis
by: Boshagh MA, et al.
Published: (2019-06-01)

CXCR1: A Cancer Stem Cell Marker and Therapeutic Target in Solid Tumors
by: Caitlin Molczyk, et al.
Published: (2023-02-01)

Evolutionarily conserved mechanisms regulating stress-induced neutrophil redistribution in fish
by: Katarzyna Klak, et al.
Published: (2024-03-01)

CXC Chemokine Signaling in Progression of Epithelial Ovarian Cancer: Theranostic Perspectives
by: Xinxin Huang, et al.
Published: (2022-02-01)

CC and CXC chemokines play key roles in the development of polyomaviruses related pathological conditions
by: Mohammad Hassan Mohammadi, et al.
Published: (2021-06-01)

Sequence characterization and expression pattern analysis of chemokines CXCL13 and CXCL14 in Asian swamp eel
by: Dingda Xu, et al.
Published: (2020-11-01)

CXCR2 antagonism promotes oligodendrocyte precursor cell differentiation and enhances remyelination in a mouse model of multiple sclerosis
by: Lu Wang, et al.
Published: (2020-02-01)

The Chemokines CXC, CC and C in the Pathogenesis of COVID-19 Disease and as Surrogates of Vaccine-Induced Innate and Adaptive Protective Responses
by: Mojgan Noroozi Karimabad, et al.
Published: (2022-08-01)

A Study of CD4, CCR3, CCR4, CCR5, CXCR3 Expression in Peripheral Blood Lymphocytes of Patients with Gastric Cancer
by: Alireza Andalib, et al.
Published: (2012-03-01)

Exploration of prognostic biomarkers and therapeutic targets in the microenvironment of bladder cancer based on CXC chemokines
by: Xiaoqi Sun, et al.
Published: (2021-07-01)

Comprehensive analysis of CXCR family members in lung adenocarcinoma with prognostic values
by: Lian-Tao Hu, et al.
Published: (2022-06-01)

Targeting G protein-coupled receptor for pain management
by: Hongyan Li, et al.
Published: (2017-01-01)

Serum Levels of CXCL13 Are an Independent Predictor of Survival Following Resection of Biliary Tract Cancer
by: Sven H. Loosen, et al.
Published: (2022-08-01)

Roles of the CXCL8-CXCR1/2 Axis in the Tumor Microenvironment and Immunotherapy
by: Zhi-Jian Han, et al.
Published: (2021-12-01)

The Role of CXC Chemokines in Cancer Progression
by: Tiantian Wu, et al.
Published: (2022-12-01)

The biological role of the CXCL12/CXCR4 axis in esophageal squamous cell carcinoma
by: Xianxian Wu, et al.
Published: (2021-05-01)

Correlation between the expressions of CXCL8 and miR-150 in the skin lesions and the severity of psoriasis vulgaris
by: MA Hui, BI Xiaodong
Published: (2023-02-01)

Expression and Function of Chemokines CXCL9-11 in Micturition Pathways in Cyclophosphamide (CYP)-Induced Cystitis and Somatic Sensitivity in Mice
by: Michael Guo, et al.
Published: (2018-04-01)

CXCR7, a Prognostic Biomarker in Cervical Squamous Cell Carcinoma, May Be a Screening Index for Treatment Options at Stages IB1 and IIA1
by: Zhao D, et al.
Published: (2019-12-01)

Inhibition of CXCR2 enhances CNS remyelination via modulating PDE10A/cAMP signaling pathway
by: Cheng Ju, et al.
Published: (2023-02-01)

Silenced CXCL12 inhibits ox-LDL-induced foaming and apoptosis in mouse macrophage cell line RAW264.7
by: ZHUANG Hong, ZHANG Su-chuan, LIU Hui-di, XU Ya-ning, HUANG Lu, DAI Tian, JIANG Pin
Published: (2021-02-01)

Gain of CXCR7 function with mesenchymal stem cell therapy ameliorates experimental arthritis via enhancing tissue regeneration and immunomodulation
by: Sung-Tai Wei, et al.
Published: (2021-05-01)

Circulating CXCR5+ natural killer cells are expanded in patients with myasthenia gravis
by: Meng‐Ru Ge, et al.
Published: (2023-01-01)

CXC ELR-Positive Chemokines as Diagnostic and Prognostic Markers for Breast Cancer Patients
by: Joanna Motyka, et al.
Published: (2023-06-01)

PPAR-γ Activation Inhibits Angiogenesis by Blocking ELR+CXC Chemokine Production in Non-small Cell Lung Cancer
by: Venkateshwar G. Keshamouni, et al.
Published: (2005-03-01)

Prognostic Biomarkers and Immunotherapeutic Targets Among CXC Chemokines in Pancreatic Adenocarcinoma
by: Jiacheng Huang, et al.
Published: (2021-08-01)

Fluorinated PEG-PEI Coated Magnetic Nanoparticles for siRNA Delivery and CXCR4 Knockdown
by: Yixiang Cao, et al.
Published: (2022-05-01)

Characterization and distribution of HIV-infected cells in semen
by: Lin Gao, et al.
Published: (2022-12-01)

The Effect of Hypoxia on the Expression of CXC Chemokines and CXC Chemokine Receptors—A Review of Literature
by: Jan Korbecki, et al.
Published: (2021-01-01)

The CXC Chemokine Receptors in Four-Eyed Sleeper (<i>Bostrychus sinensis</i>) and Their Involvement in Responding to Skin Injury
by: Mengdan Dong, et al.
Published: (2021-09-01)

Synergistic protection against hyperoxia-induced lung injury by neutrophils blockade and EC-SOD overexpression
by: Min Jae H, et al.
Published: (2012-07-01)

Comprehensive analysis of prognostic value and immune infiltration of CXC chemokines in pancreatic cancer
by: Yanhua Jing, et al.
Published: (2022-04-01)

CXC Chemokines as Therapeutic Targets and Prognostic Biomarkers in Skin Cutaneous Melanoma Microenvironment
by: Xuezhi Zhou, et al.
Published: (2021-03-01)

Risk Stratification in Acute Myeloid Leukemia Using CXCR Gene Signatures: A Bioinformatics Analysis
by: Cong Lu, et al.
Published: (2020-10-01)

Molecular Identification and Dual Functions of Two Different CXC Chemokines in Nile Tilapia (<i>Oreochromis niloticus</i>) against <i>Streptococcus agalactiae</i> and <i>Flavobacterium columnare</i>
by: Chatsirin Nakharuthai, et al.
Published: (2020-07-01)

Association of Gene Polymorphisms in CXC Chemokine Receptor 5 with Rheumatoid Arthritis Susceptibility
by: Zhenzhen Su, et al.
Published: (2022-10-01)

Exploration of potential therapeutic and prognostic value of CXC chemokines in cervical squamous cell carcinoma and endocervical adenocarcinoma based on bioinformatics analysis
by: Caiyun Wu, et al.
Published: (2021-09-01)

Expression profile and prognostic value of CXCR family members in head and neck squamous cell carcinoma
by: Yiming Shen, et al.
Published: (2022-08-01)

Effects of SDF-1/CXCR7 on the Migration, Invasion and Epithelial-Mesenchymal Transition of Gastric Cancer Cells
by: Ameng Shi, et al.
Published: (2021-11-01)